Original Source(s)
Related Content
FDA Approves Baxdrostat for Resistant Hypertension
Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.
May 18, 2026
-
2 min
Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination
Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.
May 20, 2026
-
3 min
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min